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Hypercapnia and oxygen therapy in older asthmatic patients
Joseph Y.S. Ting
Excessive oxygen administration in hypercapnic chronic
obstructive pulmonary disease predisposes to worsening
respiratory failure during intercurrent respiratory illness.
Chronic hypercapnia is thought to downregulate carbon
dioxide chemoreceptor sensitivity, adversely affecting
respiratory function/mechanics and worsening ventilation–
perfusion inequality. These patients are dependent on
hypoxic drive to maintain adequate spontaneous
respiration. Whether an analogous situation occurs in
asthma in older adults is unknown. These conditions may
be difficult to differentiate clinically, and both may respond
adversely to the administration of excessive oxygen in the
presence of chronic hypercapnia. Although unrestricted
oxygen is beneficial and safe in children and young adults
with asthma, it may lead to progressive hypercapnia in
older patients with asthma, a potential risk highlighted by
this case. To avert progressive hypercapnia, oxygen
therapy that is carefully adjusted to achieve adequate, but
not maximal, tissue oxygenation may be a safer strategy
than unrestricted oxygen use in older asthmatic patients.
However, the correction of hypoxia overrides strategies to
avert oxygen-related hypercapnia. European Journal of
Emergency Medicine 11:355–357 c 2004 Lippincott
Williams & Wilkins.
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Introduction
The effects of unrestricted oxygen administration in
elderly patients with severe late-onset chronic asthma is
undetermined, in contrast to its detrimental effects on
spontaneous respiration in chronic obstructive pulmonary
disease (COPD) patients with chronic hypercapnia.
Case report
An 80-year-old woman was admitted with chest tightness
for the exclusion of myocardial infarction. Chest ausculta-
tion revealed moderate air entry with bi-basal crackles
and no wheeze. Except for a blood pressure of 200/100
mmHg, the rest of her cardiovascular examination was
normal. There was no acute ischaemic change on serial
electrocardiogram and the troponin-I levels did not rise.
There was no history of ischaemic heart disease or risk
factors for pulmonary thromboembolism.
There was a long history of severe late-onset asthma, with
premorbid spirometry of a forced expiratory volume in 1 s
(FEV1) of 0.37 l (23% predicted) and a forced vital
capacity of 0.74 l (27% predicted). There was no history
of direct or indirect exposure to cigarette smoking. She
was maintained on 10mg prednisone daily but had no
home oxygen requirement, mobilized independently and
was self-caring. Other medical problems included well-
controlled, non-insulin-dependent diabetes mellitus,
poorly controlled hypertension, gastro-oesophageal reflux,
and osteoporosis. Her medications were inhaled salbuta-
mol, ipratropium bromide, budesonide and salmeterol;
theophylline, zafirlukast, prednisone, metformin, glipi-
zide, ramipril, lansoprazole, calcitriol and rofecoxib.
That evening, she became gradually more hypertensive to
250/95mmHg. Oxygen 6 l/min was applied by nursing
staff, after which she rapidly became unresponsive. Her
pulse rate was 88 beats/min, arterial oxygen saturation
(SaO2) 78%, respiratory rate 30 breaths/min, and tem-
perature 361C. The blood sugar level was 11mmol/l.
There was no wheeze. Although severe hypertension
responded well to intravenous hydralazine, her conscious-
ness level did not improve. She had not received
parenteral narcotics or beta-blockers before her
deterioration.
The decision not to ventilate the patient mechanically
was made in consultation with her family, in view of the
possibility of a catastrophic brain-stem event, her age, and
poor respiratory function. SaO2 deteriorated further to
66%. Arterial blood gases (ABG) on room air showed
pH7.10 [relative risk (RR) 7.35–7.45], arterial carbon
dioxide tension (PaCO2) 139 (RR 36–45mmHg), arterial
oxygen tension (PaO2) 37 (RR 70–80mmHg), bicarbonate
42 (RR 22–29mmol/l), and base excess + 6.8 (RR
–3.0–4.0mmol/l), consistent with acute-on-chronic respira-
tory failure. Chest X-ray showed left basal atelectasis and
consolidation. Intravenous ceftriaxone was commenced.
The patient received regular inhaled salbutamol, ipra-
tropium bromide, and budesonide, as well as intravenous
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hydrocortisone. The SaO2 improved to more than 90%
after oxygen was reduced to 3 l/min, but she had
recurrent apnoea. Repeat ABG demonstrated worsening
respiratory acidosis and hypercapnia despite improved
oxygenation (pH6.96, PaCO2 154mmHg, PaO2 94mmHg,
bicarbonate 33mmol/l, base excess + 1.1mmol/l). A
paradoxical improvement in PaO2 achieved by reducing
delivered oxygen strongly suggested that over-treatment
with oxygen had a harmful effect in this setting.
The patient remained unresponsive with pinpoint non-
reactive pupils. There was symmetrical hypotonicity,
arreflexia and absent plantar responses. She was not
hypoglycaemic at any stage, and severe hypertension had
responded well to treatment. The most likely diagnosis
was considered to be a brain-stem cerebrovascular event
associated with central hypercapnic hypoxic respiratory
failure and reduced consciousness.
A non-contrast computed tomography head scan per-
formed on the morning of the second admission day
demonstrated an equivocal low-density lesion in the
brainstem (this was absent on subsequent scans,
suggesting an artefact). Oxygen was reduced to 2 l/min.
Soon thereafter, her neurological state improved rapidly,
and her recovery was complete by the morning of the
third admission day.
ABG on air after recovery showed pH7.39, PaCO2
58mmHg, PaO2 54mmHg, bicarbonate 34mmol/l, base
excess + 7.1mmol/l. The patient was discharged on
1 l/min home oxygen. Pulmonary function was improved
at discharge (FEV1 0.68 l, forced vital capacity 0.93 l)
and she remains independent and self-caring.
A sleep study demonstrated no obstructive sleep apnoea.
Increased apnoeic and hypopnoeic events that were
associated with hypercapnia did not increase arousal,
consistent with reduced respiratory centre sensitivity to
carbon dioxide.
Discussion
This elderly patient suffered unexpected acute-on-
chronic respiratory failure related to long-standing asthma
despite an admission for chest pain. She was at high risk
of severe deterioration from asthma, given previous
severe episodes, an intercurrent PaCO2 greater than
97mmHg and pH less than 7 [1]. Acute deterioration
in consciousness led to an initial diagnosis of brain-stem
dysfunction with centrally mediated respiratory failure.
This was revised after she made a complete neurological
recovery.
Respiratory acidosis and hypercapnia during acute ex-
acerbation of asthma and COPD leads to neurological and
cardiorespiratory dysfunction, such as altered conscious-
ness, tachycardia and hypertension [2–4]. These clinical
manifestations are associated with increased mortality
[5]. Hypertensive encephalopathy was unlikely as her
consciousness level remained poor despite improved
hypertension.
Hypoxia is more rapidly harmful to tissues than
hypercarbia, and if both are present, hypoxia requires
more urgent correction with supplemental oxygen,
even at the expense of worsening hypercarbia [6].
Hypercapnia indicates respiratory fatigue and warrants
the consideration of assisted ventilation [7,8]. Although
oxygen in addition to bronchodilators and steroids are
effective in acute severe asthma in children and young
adults [7,8], our case illustrates the potential for
older asthmatic individuals to deteriorate with unrest-
ricted oxygen administration. In these situations, respira-
tory failure, hypoxia and hypercapnia improve with a
careful reduction in oxygen concentration that is
still capable of maintaining acceptable tissue oxygenation
(SaO2> 90%).
Whether unrestricted oxygen administration predisposes
to hypercapnia and worsening respiratory failure in severe
asthma in older adults is unclear [9]. Chien et al. [10]
found that the administration of 100% oxygen [fractional
inspired oxygen (FIO2) 100%] for 20min in moderate
asthmatic patients with respiratory alkalosis and hypo-
carbia led to carbon dioxide retention. Hypercapnia was
worse the more severe the episode of asthma. There was
no confounding effect from bronchodilators in that study,
as oxygen was commenced before bronchodilators. As
FEV1 remained stable during the study period, progres-
sive hypercapnia was not felt to be caused by progressive
asthma. As in our case, several patients became less
hypercapnic as oxygen was reduced.
A safe FIO2 threshold before ABG measurement for acute
severe asthma in the elderly remains undetermined.
There are no studies on oxygen safety in elderly
asthmatic patients. Ford and Rothwell [9] and McFadden
and Lyons [11] found an FIO2 up to 35% effective in
young adults with moderate to severe asthma without
predisposing to hypercapnia. FIO2 up to 60% safely
relieves hypoxia during normocapnic exacerbation of
asthma in adults [8].
As SaO2 less than 90% occurs in less than 2% of asthma
exacerbations, adequate oxygenation can usually be
attained with oxygen starting at 2–4 l/min [10]. Slowly
increasing oxygen administration to maintain a PaO2
greater than 60mmHg is recommended in acute asthma
[9,12] and COPD [2], especially when there is pre-
existing or worsening hypercapnia [8,13]. This reduces
the risk of worsening hypercapnia while maintaining
adequate oxygenation [14]. SaO2 and PaO2 monitoring
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using pulse oximetry and ABG, respectively, during
oxygen titration averts hypoxia [9].
Late-onset asthmatic individuals with a PaCO2 greater
than 45mmHg may be at risk of worsening hypercapnia
with unrestricted oxygen administration [8]. This may
evolve within minutes [13,15]. Our patient’s recovery
demonstrates the capacity of the older hypercapnic
asthmatic patient to recover with simple measures such
as reduced oxygen administration [2,16,17], although
assisted ventilation will often be required [18] if
hypercapnia is acute and reflects fatigue rather than
over-oxygenation.
The effect of chronic hypercarbia on respiratory drive in
asthma is not known, unlike in COPD, in which acute-on-
chronic and chronic hypercapnia dampens the hypoxic
respiratory drive [2,3,5,13–15,19]. Unrestricted oxygen
administration in a COPD patient with chronic hyper-
capnia leads to centrally mediated alveolar hypoventila-
tion, reduced hypoxic drive, and worsening respiratory
acidosis [3,10,13,20]. Chronic hypercapnia results in
reduced chemosensitivity to carbon dioxide and increased
reliance on hypoxic drive to maintain breathing during an
intercurrent respiratory illness [2,14,17,20–22]. In these
patients, unrestricted oxygen suppresses the hypoxic
drive leading to reduced minute ventilation and carbon
dioxide retention [14,20]. Worsening ventilation–perfu-
sion mismatch and increased dead space ventilation were
found to be significant in more recent studies [13,23].
COPD patients with chronic hypercapnia experience
worsening respiratory acidosis the more the SaO2 is
corrected above 92% [5]. Westlake et al. [2], Aubier et al.
[13], Donald [16], and Prime and Westlake [17]
described respiratory deterioration in chronically hyper-
capnic patients after unrestricted oxygen therapy, which
improved with reducing oxygen administration. A chronic
PaCO2 of more than 50mmHg increases the risk of
progressive hypercapnia in stable COPD [15], and
titrated oxygen therapy aiming to maintain the SaO2 at
90–92% is recommended [3].
Conclusion
Unrestricted oxygen administration is beneficial in
children and young adults with asthma, but may lead to
progressive hypercapnia in older asthmatic individuals
[7], a potential risk highlighted by this case. It is difficult
to differentiate between COPD and asthma in elderly
patients, and both conditions may deteriorate in response
to over-oxygenation. This risk is reduced by carefully
titrated oxygen therapy that provides adequate tissue
oxygenation without provoking progressive hypercapnia.
However, ensuring adequate tissue oxygenation should
take precedence over averting progressive oxygen-in-
duced hypercapnia.
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